Coding sequence haplotype of the human BRCA1 gene

• US 6,686,163 B2
• Filed: 12/20/2001
• Issued: 02/03/2004
• Est. Priority Date: 05/06/1998
• Status: Expired due to Fees

• Current Assignee: Myriad Genetics
• Original Assignee: Gene Logic, Inc. (Steel Partners Holdings LP)
• Inventors: Rabin, Mark B., Olson, Sheri J., Allen, Antonette C. P., Lawrence, Tammy, Angelly, Tracy S.
• Primary Examiner(s): Horlick, Kenneth R.
• Assistant Examiner(s): WILDER, CYNTHIA B
• Application Number:
  US10/022,819
• Publication Number:
  US 20030027166A1
• Time in Patent Office: 775 Days
• Field of Search: 536/23.1, 536/24.3, 536/23.2, 536/23.5, 435/320.1, 435/6, 435/325, 435/69.1, 514/44, 530/350, 530/300
• US Class Current: 435/6.12
• CPC Class Codes: A61K 38/00 Medicinal preparations containing peptides peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergot alkaloids of the cyclic peptide type A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00
• CPC Class Codes: A61K 48/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
• CPC Class Codes: C07K 14/4703 Inhibitors; Suppressors

Abstract

The invention is directed to isolated coding sequences and to the protein sequences they code for. The coding sequence for BRCA1(omi4) gene is provided together with the protein sequence it codes for. The BRCA1(omi4) sequence is used for identifying an individual having an increased genetic susceptibility to breast or ovarian cancer because the patient has an inherited causative mutation in their BRCA1 gene. This invention is also related to a method of performing gene therapy with the isolated BRCA1(omi4) coding sequence and protein replacement therapy with the BRCA1(omi4) protein.

Claims

1. An isolated nucleic acid molecule that encodes a BRCA1 protein comprising a first nucleotide substitution of adenine for guanine at a position corresponding to nucleotide 3232 of SEQ ID NO:

1, and a second nucleotide substitution of cytosine for thymine at a position corresponding to nucleotide 4427 of SEQ ID NO;

1, and fragments thereof containing the first and second nucleotide substitutions.

2. The isolated nucleic acid molecule of claim 1, wherein the nucleic acid molecule encoding the BRCA1 protein further comprises one or more additional nucleotide substitutions selected from the group consisting of:

(a) a cytosine for thymine substitution at a position corresponding to nucleotide 2201 of SEQ ID NO;

1,

(b) a thymine for guanine substitution at a position corresponding to nucleotide 2430 of SEQ ID NO;

1,

(c) a thymine for cytosine substitution at a position corresponding to nucleotide 2731 of SEQ ID NO;

1,

(d) a guanine for adenine substitution at a position corresponding to nucleotide 3667 of SEQ ID NO;

1, and

(e) a guanine for adenine substitution at a position corresponding to nucleotide 4956 of SEQ ID NO;

1.

3. The isolated nucleic acid molecule of claim 1, wherein the fragment thereof containing the first and second nucleotide substitutions further comprises one or more substitutions selected from the group consisting of:

(a) a cytosine for thymine substitution at a position corresponding to nucleotide 2201 of SEQ ID NO;

1,

(b) a thymine for guanine substitution at a position corresponding to nucleotide 2430 of SEQ ID NO;

1,

(c) a thymine for cytosine substitution at a position corresponding to nucleotide 2731 of SEQ ID NO;

1,

(d) a guanine for adenine substitution at a position corresponding to nucleotide 3667 of SEQ ID NO;

1, and

(e) a guanine for adenine substitution at a position corresponding to nucleotide 4956 of SEQ ID NO;

1.

4. The isolated nucleic acid molecule of claim 1, wherein the nucleic acid comprises the nucleotide sequence of SEQ ID NO:

1.

5. The isolated nucleic acid molecule of claim 4, wherein the nucleic acid molecule consists of the nucleotide sequence of SEQ ID NO:

1.

6. The isolated nucleic acid molecule of claim 1, wherein the nucleic acid molecule comprises nucleotides 120 to 5,708 of SEQ ID NO:

1.

7. The isolated nucleic acid molecule of claim 6, wherein the nucleic acid molecule consists of nucleotides 120 to 5,708 of SEQ ID NO:

1.

8. The isolated nucleic acid molecule of claim 1, wherein the nucleic acid molecule encodes a BRCA1 protein with a glutamate residue at a position corresponding to amino acid 1038 of SEQ ID NO:

2.

10. The isolated nucleic acid molecule of claim 8 or 9, wherein the nucleic acid molecule encodes a BRCA1 protein comprising SEQ ID NO:

2.

11. The isolated nucleic acid molecule of claim 8 or 9, wherein the nucleic acid molecule encodes a BRCA1 protein consisting of SEQ ID NO:

2.

17. The isolated nucleic acid molecule of claim 1 or 9, wherein said nucleic acid molecule is operably linked to one or more expression control elements.

18. A vector comprising an isolated nucleic acid molecule of claim 1 or 9.

19. A host cell comprising the vector of claim 18.

20. A host cell transformed to contain the nucleic acid molecule of claim 1 or 9.

21. A host cell of claim 20, wherein said host is selected from the group consisting of prokaryotic hosts and eukaryotic hosts.

22. A method for producing a polypeptide comprising culturing a host cell of claim 20 under conditions in which the protein encoded by the nucleic acid molecule is expressed.

23. The method of claim 22, wherein said host cell is selected from the group consisting of prokaryotic hosts and eukaryotic hosts.

9. An isolated nucleic acid molecule that encodes a BRCA1 protein containing a glutamate residue at a position corresponding to amino acid 1038 of SEQ ID NO:

2 and a serine residue at a position corresponding to amino acid 1436 of SEQ ID NO;

1.

12. The isolated nucleic acid molecule of claim 9, wherein the nucleic acid molecule contains a adenine at a position corresponding to nucleotide 3232 of SEQ ID NO:

1 and a cytosine at a position corresponding to nucleotide 4427 of SEQ ID NO;

1.

13. The isolated nucleic acid molecule of claim 9, wherein the nucleic acid molecule comprises SEQ ID NO:

1.

14. The isolated nucleic acid molecule of claim 13, wherein the nucleic acid molecule consists of SEQ ID NO:

1.

15. The isolated nucleic acid molecule of claim 9, wherein the nucleic acid molecule comprises nucleotides 120 to 5,708 of SEQ ID NO:

1.

16. The isolated nucleic acid molecule of claim 15, wherein the nucleic acid molecule consists of nucleotides 120 to 5,708 of SEQ ID NO:

1.

24. A nucleic acid molecule of about 10 to about 100 nucleotides which specifically hybridizes to a nucleic acid molecule encoding a BRCA1 protein that contains an adenine for guanine substitution at a position corresponding to nucleotide 3232 of SEQ ID NO:

1.

25. A nucleic acid molecule of about 10 to about 100 nucleotides which specifically hybridizes to a nucleic acid molecule encoding a BRCA1 protein that contains a cytosine for thymine substitution at a position corresponding to nucleotide 4427 of SEQ ID NO:

1.